APA
Ahmed A., Merrill S. A., Alsawah F., Bockenstedt P., Campagnaro E., Devata S., Gitlin S. D., Kaminski M., Cusick A., Phillips T., Sood S., Talpaz M., Quiery A., Boonstra P. S. & Wilcox R. A. (20191209). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. : The Lancet. Haematology.
Chicago
Ahmed Asra, Merrill Samuel A, Alsawah Fares, Bockenstedt Paula, Campagnaro Erica, Devata Sumana, Gitlin Scott D, Kaminski Mark, Cusick Alice, Phillips Tycel, Sood Suman, Talpaz Moshe, Quiery Albert, Boonstra Philip S and Wilcox Ryan A. 20191209. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. : The Lancet. Haematology.
Harvard
Ahmed A., Merrill S. A., Alsawah F., Bockenstedt P., Campagnaro E., Devata S., Gitlin S. D., Kaminski M., Cusick A., Phillips T., Sood S., Talpaz M., Quiery A., Boonstra P. S. and Wilcox R. A. (20191209). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. : The Lancet. Haematology.
MLA
Ahmed Asra, Merrill Samuel A, Alsawah Fares, Bockenstedt Paula, Campagnaro Erica, Devata Sumana, Gitlin Scott D, Kaminski Mark, Cusick Alice, Phillips Tycel, Sood Suman, Talpaz Moshe, Quiery Albert, Boonstra Philip S and Wilcox Ryan A. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. : The Lancet. Haematology. 20191209.